evidence: We found that the DNA prime-rAd5 boost vaccine induced a significant cross-clade HIV-specific antibody response, which correlated with antibody neutralization efficiency.
intervention: DNA prime-rAd5 boost vaccine
comparator: Control
outcome: Signal intensities against EnvA at week 36